Join Dr. Clancy and his guests, Kira Blum, Dr. Schleich, and Dr. Slayman, as they discuss guidance for clinicians with their patients regarding the ever-expanding options with dietary and herbal supplements, high protein products and sports drinks. CME credit is available.
News
Daniel Tranel, PhD, is celebrated for his unwavering enthusiasm and dedication to mentoring.
Carver College of Medicine grad Kyle Glienke (13MD) reflects on his calling to rural and agricultural medicine and his place in Storm Lake, Iowa—the community he loves.
As UI Health Care works to increase access for all Iowans, the organization is actively adopting new, innovative technologies to support its teams, reduce the administrative burden involved with patient care, and enable a stronger connection with patients.
Stephen Rumelhart (86PA) has led a career marked by his dedication to hematology and oncology, his long-standing commitment to patient care at the University of Iowa, and his emphasis on teamwork and collaboration.
Incoming biomedical sciences graduate student Cobey (Heinen) Donelson's love for the lab led him to a PhD program at Iowa.
University of Iowa researchers in engineering, otolaryngology, and neurology are working to improve treatment planning for those struggling with obstructive sleep apnea (OSA), a common cause of snoring. Sajan Goud Lingala, assistant professor of biomedical engineering and radiology, is the principal investigator on the project.
GI physician El Abiad has pioneered several innovative techniques to treat rare radiation-induced trachea and esophageal problems.
Biologics are complex, high-cost treatments derived from living systems, used for immune-related disorders. Biosimilars are more affordable alternatives that are highly similar to biologics, with no significant clinical differences. The FDA supports biosimilar development to reduce costs, and various financial aids are available to help patients access these treatments. Join us as we discuss these important topics. CME credit available for listening.